Clinical trial
On Demand Treatment of Reflux Disease
NCT00184522 · Norwegian University of Science and Technology, Other · Completed
Key facts
| NCT number | NCT00184522 |
|---|---|
| Title | On Demand Treatment of Reflux Disease |
| Official title | Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease. |
| Lead sponsor | Norwegian University of Science and Technology, Other |
| Collaborators | Ferrosan AS Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux |
| Intervention type | Drug |
| Interventions | Aflurax, esomeprazole |
| Enrollment | 82 |
| Start date | Aug 1, 2002 |
| Primary completion | Nov 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 9, 2011 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: